Order Article Reprints

Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers. 2020; 12(3):713. https://doi.org/10.3390/cancers12030713

Castellví, Marc, Eudald Felip, Ifeanyi Jude Ezeonwumelu, Roger Badia, Edurne Garcia-Vidal, Maria Pujantell, Lucía Gutiérrez-Chamorro, Iris Teruel, Anna Martínez-Cardús, Bonaventura Clotet, and et al. 2020. "Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy" Cancers 12, no. 3: 713. https://doi.org/10.3390/cancers12030713

Castellví, M., Felip, E., Ezeonwumelu, I. J., Badia, R., Garcia-Vidal, E., Pujantell, M., Gutiérrez-Chamorro, L., Teruel, I., Martínez-Cardús, A., Clotet, B., Riveira-Muñoz, E., Margelí, M., Esté, J. A., & Ballana, E. (2020). Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers, 12(3), 713. https://doi.org/10.3390/cancers12030713